Company news
Renalytix PLC news in 2022
Renalytix PLC's news releases, calls and decks from 2022, newest first.
Clinical utility study data: further highlights
December 1, 2022
Results for First Quarter of Fiscal Year 2023
November 30, 2022
Publication of new real world evidence
November 29, 2022
Notice of Q1 FY23 Results
November 22, 2022
Publication of Annual Report 2022 & Notice of AGM
November 10, 2022
RENX to Present at Stifel Healthcare Conference
November 3, 2022
Renalytix Reports Full Year Fiscal 2022 Results
October 31, 2022
KidneyIntelX Medicare Update
October 25, 2022
Presentations accepted at ASN Kidney Week
October 17, 2022
Issue of shares
September 12, 2022
Renalytix to Present at H.C. Wainwright Conference
September 8, 2022
Business update
August 17, 2022
Publication of clinical utility study in The AJMC
August 8, 2022
Renalytix Reports Financial Results for Q3 of FY22
June 30, 2022
Renalytix to Report Financial Results for Q3
June 23, 2022
Mount Sinai clinical utility data
June 10, 2022
Renalytix to Present at Growth Stock Conference
June 8, 2022
Data Presentations at ADA 82nd Scientific Sessions
June 6, 2022
Successful completion of $30.0m financing package
April 8, 2022
$30.0 million financing package
March 31, 2022
Timothy Scannell appointed to the Board
March 30, 2022
Enrollment Milestone for KidneyIntelX
March 29, 2022
Renalytix Launches myIntelX
March 9, 2022
Presentation of new clinical data for KidneyIntelX
February 24, 2022
RENX to Present at Cowen 42nd Annual Conference
February 22, 2022
Conference attendance
January 27, 2022
Positive Study Results Published for KidneyIntelX
January 11, 2022
Partnership with Singing River for KidneyIntelX
January 10, 2022
Appointment of Jean M. Casner as CHRO
January 7, 2022
RENX to present at 40th JP Morgan Healthcare Conf.
January 5, 2022
Joint program with American Diabetes Association
January 4, 2022